What are the differences in myopathy between hydrophilic and lipophilic statins?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The evidence does not consistently show significant differences in the risk of statin-associated myopathy between hydrophilic and lipophilic statins, although hypotheses exist regarding potentially lower myopathy risk for hydrophilic statins due to reduced muscle cell diffusion.

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Cancer Lipids and Metabolism Muscle Physiology and Disorders

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
26 March 2026
Language
EN